US HB7839 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 29 2020 - 25% progression, died in committee
Action: 2020-07-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 29 2020 - 25% progression, died in committee
Action: 2020-07-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
Title
Continuing Access to In-Home IVIG Act
Sponsors
| Rep. Doris Matsui [D-CA] | Rep. Kevin Brady [R-TX] | Rep. Brad Wenstrup [R-OH] | Rep. David Schweikert [R-AZ] |
| Rep. Ed Case [D-HI] | Rep. Josh Harder [D-CA] | Rep. Tom Cole [R-OK] | Rep. Robin Kelly [D-IL] |
| Rep. Adrian Smith [R-NE] | Rep. Grace Napolitano [D-CA] | Rep. Sheila Jackson-Lee [D-TX] | Rep. George Holding [R-NC] |
| Rep. G. Butterfield [D-NC] | Rep. Derek Kilmer [D-WA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-07-29 | House | Referred to the Subcommittee on Health. |
| 2020-07-29 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-07-29 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-07-29 | House | Introduced in House |
Subjects
Congressional oversight
Drug therapy
Government studies and investigations
Health
Health programs administration and funding
Health technology, devices, supplies
Hereditary and development disorders
Home and outpatient care
Immunology and vaccination
Medicare
Drug therapy
Government studies and investigations
Health
Health programs administration and funding
Health technology, devices, supplies
Hereditary and development disorders
Home and outpatient care
Immunology and vaccination
Medicare
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/7839/all-info |
| Text | https://www.congress.gov/116/bills/hr7839/BILLS-116hr7839ih.pdf |
